ArticlePloS one2016

CXCR7/p-ERK-Signaling Is a Novel Target for Therapeutic Vasculogenesis in Patients with Coronary Artery Disease.

Zheng Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.